Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2009-05-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches
NCT00750217
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
NCT00471042
Comparison of Buprenorphine and Methadone - 3
NCT00000334
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
NCT00879996
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Buprenorphine
opioid-dependent patients with buprenorphine substitution
interview
interview using questionnaires
methadone
opioid-dependent patients substituted with methadone
interview
interview using questionnaires
no substitution
opioid-dependent patients without substitution
interview
interview using questionnaires
therapists
therapists of the patients
interview
interview using questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview
interview using questionnaires
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Opioid-dependent with substitution with buprenorphine,
* methadone or without substitution
* Sufficient knowledge of German language
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Psychiatric University Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Psychiatric University Hospital Zurich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukas Boesch, PhD
Role: STUDY_CHAIR
Psychiatric University Hospital, Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychiatric University Hospital
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-10/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.